A
Anat Mirelman
Researcher at Tel Aviv Sourasky Medical Center
Publications - 246
Citations - 12440
Anat Mirelman is an academic researcher from Tel Aviv Sourasky Medical Center. The author has contributed to research in topics: Medicine & Gait (human). The author has an hindex of 47, co-authored 208 publications receiving 9246 citations. Previous affiliations of Anat Mirelman include Harvard University & Ben-Gurion University of the Negev.
Papers
More filters
Journal ArticleDOI
The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of events.
Aner Weiss,Talia Herman,Anat Mirelman,Shirley Shema Shiratzky,Nir Giladi,Lisa L. Barnes,David A. Bennett,Aron S. Buchman,Jeffrey M. Hausdorff,Jeffrey M. Hausdorff,Jeffrey M. Hausdorff +10 more
TL;DR: Poorer postural and gait control are associated with the strategy choice and with the duration of concurrent performance of turning and sitting when patients with Parkinson's disease transition from turning to sitting.
Journal ArticleDOI
A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis.
Nir Giladi,Nir Giladi,Anat Mirelman,Anat Mirelman,Avner Thaler,Avner Thaler,Avi Orr-Urtreger,Avi Orr-Urtreger +7 more
TL;DR: It is believed that sufficient evidence has accumulated to warrant the initiation of personalized medicine in PD based on subjects genotype and examples for this reasoning are provided from observations of GBA and LRRK2 mutations carriers.
Journal ArticleDOI
Fall risk is associated with amplified functional connectivity of the central executive network in patients with Parkinson’s disease
Keren Rosenberg-Katz,Talia Herman,Talia Herman,Yael Jacob,Yael Jacob,Anat Mirelman,Nir Giladi,Talma Hendler,Jeffrey M. Hausdorff,Jeffrey M. Hausdorff +9 more
TL;DR: Mediation analysis demonstrated that the relationships between caudate head gray matter volume and fall history and risk were mediated by increased connectivity within the central executive network, apparently via attentional changes.
Journal ArticleDOI
Prefrontal cortex activation during obstacle negotiation: What's the effect size and timing?
Inbal Maidan,Inbal Maidan,Shiran Shustak,Topaz Sharon,Hagar Bernad-Elazari,Nimrod Geffen,Nir Giladi,Jeffrey M. Hausdorff,Anat Mirelman +8 more
TL;DR: These findings are the first to show that the pattern of prefrontal activation depends on the nature of the obstacle, and during unanticipated obstacles the recruitment of the prefrontal cortex is faster and greater than during negotiating anticipated obstacles.
Journal ArticleDOI
Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
Orly Goldstein,Mali Gana-Weisz,Danielle Cohen-Avinoam,Tamara Shiner,Avner Thaler,Jesse M. Cedarbaum,Sally John,Maria Lalioti,Tanya Gurevich,Anat Bar-Shira,Anat Mirelman,Nir Giladi,Avi Orr-Urtreger,Avi Orr-Urtreger +13 more
TL;DR: A higher frequency of PD patients that carry two mutations is demonstrated, and an additive effect on risk and earlier AAO was proposed for carriers of LRRK2/mild-GBA double mutations, and these data support an oligogenic approach to PD genetics.